Hepatocellular carcinoma (HCC) remains one of the deadliest malignancies worldwide, with limited therapeutic options and a poor prognosis that continues…
Credit: Charles River Laboratories Ardena Acquired Catalent’s Somerset, NJ, oral solids development and small-scale drug product manufacturing facility for an…